Mastitis treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/573 (2006.01) A61K 31/545 (2006.01) A61K 31/546 (2006.01) A61P 29/00 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2508022

A pharmaceutical composition for intramammary administration to a nonhuman mammal comprising an antibacterial agent and prednisolone wherein the composition comprises at least 20 mg of prednisolone and its use for the treatment of clinical mastitis.

L'invention porte sur une composition pharmaceutique destinée à être administrée par voie intramammaire à un mammifère et comprenant un agent antibactérien et la prednisolone. La composition comprend au moins 20 mg de prednisolone et peut être utilisée dans le traitement de la mastite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mastitis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mastitis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mastitis treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1564048

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.